INCOME STATEMENT
Rossari Biotech Ltd.
BSE
Apr 30
659.70
-20.60 ( -3.03%)
Volume
5274
Prev. Close
680.30
Open Price
671.00
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
0.00 (0)
NSE
Apr 30
658.05
-22.90 ( -3.36%)
Volume
93955
Prev. Close
680.95
Open Price
671.30
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
0.00 (0)
You can view the
Income Statement
for the last 5 years.
|
ISIN No
|
INE02A801020
|
Market Cap. ( ₹ in Cr. )
|
3643.40
|
P/BV
|
3.26
|
Book Value ( ₹ )
|
201.88
|
|
BSE Code
|
543213
|
52 Week High/Low ( ₹ )
|
973/569
|
FV/ML
|
2/1
|
P/E(X)
|
26.72
|
|
NSE Code
|
ROSSARIEQ
|
Book Closure
|
11/11/2024
|
EPS ( ₹ )
|
24.63
|
Div Yield (%)
|
0.08
|
(₹ in Crs.)
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | PR | AR | AR | AR | AR |
| FaceValue | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| | | | | | |
| | | | | | |
| INCOME | | | | | |
| Revenue From Operations [Net] | 1431.63 | 1188.80 | 969.20 | 1064.04 | 688.48 |
| Other Operating Revenues | 0.00 | 14.11 | 5.98 | 8.81 | 1.94 |
| Total Operating Revenues | 1431.63 | 1202.91 | 975.17 | 1072.84 | 690.41 |
| | | | | | |
| Other Income | 5.74 | 6.77 | 3.60 | 12.70 | 10.21 |
| Total Revenue | 1437.37 | 1209.68 | 978.77 | 1085.54 | 700.62 |
| | | | | | |
| EXPENSES | | | | | |
| Cost Of Materials Consumed | 811.12 | 625.73 | 553.96 | 707.98 | 433.88 |
| Purchase Of Stock-In Trade | 253.00 | 284.99 | 163.33 | 122.29 | 24.99 |
| Changes In Inventories Of FG,WIP And Stock-In Trade | -17.04 | -13.58 | -12.97 | -10.34 | -7.22 |
| Employee Benefit Expenses | 60.01 | 51.46 | 57.35 | 43.53 | 36.66 |
| Finance Costs | 9.58 | 9.70 | 4.62 | 2.55 | 2.99 |
| Depreciation And Amortisation Expenses | 27.69 | 24.19 | 25.98 | 26.27 | 22.07 |
| Other Expenses | 138.31 | 93.05 | 90.87 | 86.59 | 81.26 |
| Total Expenses | 1282.67 | 1075.55 | 883.13 | 978.86 | 594.63 |
| | | | | | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 154.70 | 134.13 | 95.65 | 106.68 | 106.00 |
| | | | | | |
| Profit/Loss Before Tax | 154.70 | 134.13 | 95.65 | 106.68 | 106.00 |
| | | | | | |
| Tax Expenses-Continued Operations | | | | | |
| Current Tax | 39.96 | 36.16 | 25.97 | 28.72 | 27.53 |
| Deferred Tax | 0.00 | -1.67 | -1.71 | -1.51 | -0.63 |
| Total Tax Expenses | 39.96 | 34.49 | 24.26 | 27.21 | 26.90 |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 114.74 | 99.65 | 71.39 | 79.47 | 79.10 |
| | | | | | |
| Profit/Loss From Continuing Operations | 114.74 | 99.65 | 71.39 | 79.47 | 79.10 |
| | | | | | |
| Profit/Loss For The Period | 114.74 | 99.65 | 71.39 | 79.47 | 79.10 |
| | | | | | |
| OTHER INFORMATION | | | | | |
| | | | | | |
| EARNINGS PER SHARE | | | | | |
| Basic EPS (Rs.) | 20.75 | 18.05 | 12.95 | 14.49 | 15.34 |
| Diluted EPS (Rs.) | 20.72 | 18.01 | 12.90 | 14.40 | 15.25 |
| | | | | | |
| DIVIDEND AND DIVIDEND PERCENTAGE | | | | | |
| Equity Share Dividend | 0.00 | 2.76 | 2.75 | 2.75 | 2.54 |
| Equity Dividend Rate (%) | 25.00 | 25.00 | 25.00 | 25.00 | 25.00 |